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INTRODUCTION
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart-muscle disease, 
characterized by myocardial atrophy, fibro-fatty replacement, and ventricular arrhythmias, that 
primarily affects the right ventricle (RV).[1] With time, ARVC leads to diffuse RV and left ventricle 
(LV) involvement and may be difficult to distinguish clinically from dilated cardiomyopathy.[2,3]
Different distinct patterns of the disease have been reported, which include isolated RV 
disease, prominent LV manifestations in the setting of relatively mild right-sided disease; 
ABSTRACT
Objectives: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited  heart-muscle disease, 
characterized by fibro-fatty replacement and ventricular arrhythmias, that primarily affects the  right ventricle 
(RV). We aimed to look at the clinical presentation, cardiac magnetic resonance (CMR) imaging findings and 
prognosis of patients with ARVC in Pakistan.
Material and Methods: It is a retrospective observational study, 17 consecutive patients with CMR and other 
findings consistent with ARVC, were enrolled from 2010 to 2019 at a single center.
Results: Out of 17 patients, 12 (70.6%) were male with a mean age of 33.5 ± 17.5 years. Family history of sudden 
cardiac death was present in 3 (17.7%) patients while one (5.9%) patient had family history of ARVC. Syncope 
was the first presenting symptom in eight (47.1%) patients. On 12 leads ECG, T wave inversion in precordial leads 
was found in 6 (35.4%) patients, and epsilon wave was present in only 3 (17.7%) patients. On echocardiogram, 13 
(76.5%) patients had dilated RV with reduced systolic function. On CMR, majority of patients (n = 14, 82.4%) were 
found to have RV dilatation with regional dyskinesia and fatty infiltration, 9 (52.9%) of them had left ventricular 
involvement also. Follow-up was available for 14 patients (82.4%) with a mean follow-up period of 35.5 ± 19.7 
months. ree (21.4%) of them died and 10 (71.4%) got admissions for heart failure during follow-up period.
Conclusion: Arrhythmia related events are the main presenting symptoms of ARVC in this region, and left 
ventricular involvement in ARVC is not rare in this population. e mortality is relatively high, probably due to 
advanced disease at the time of presentation and less medical facilities available.
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and biventricular disease.[4] e LV involvement is 
associated with more severe cardiomyopathy, inflammatory 
infiltrates, and heart failure.[4,5] Natural history of disease 
is divided into four phases. A subclinical phase (with 
concealed structural abnormalities and no symptoms 
but sudden death  might be the first manifestation in this 
phase), followed by an overt RV electrical disorder with 
ventricular  arrhythmias  originating from the RV. ird, 
RV failure due to progressive loss of  myocardium  with 
severe dilatation and  systolic dysfunction  and finally an 
end stage biventricular involvement that can mimic dilated 
cardiomyopathy.[6]
Electrocardiographic (ECG) changes and arrhythmias 
may develop before histological evidence of myocytes loss 
or clinical evidence of RV dysfunction and are early and 
sensitive markers of disease expression in ARVC.[6] e 
subclinical phase of disease may also be detected by imaging 
studies, and cardiac magnetic resonance (CMR) imaging is 
one of the most sensitive imaging modality which not only 
helps in morphological and functional assessment but also 
helps in tissue characterization.[7]
ere are no data on ARVC from our population. Our 
hospital has been the pioneer of cardiac imaging in the 
country. It serves as the only center offering CMR facility 
to a large area of population and hence has been a referral 
center for CMR in patients with suspected ARVC. We 
aim to study the clinical presentation, CMR findings, 
and prognosis of patients with ARVC. is will help us 
understand the characteristics and prognosis of ARVC in 
our population.
MATERIAL AND METHODS
Study design
is is a retrospective observational study.
Study population
is study was approved by the hospital ethical review 
committee. Forty-three patients with clinical signs and 
symptoms suggestive of ARVC who were referred to Aga 
khan university hospital, Karachi, Pakistan, for CMR from 
2010 to 2019, were evaluated for inclusion criteria. Seventeen 
patients who met the CMR criteria for ARVC[8] [Table  1] 
were retrospectively included in this study and rest of them 
were excluded from the study. e diagnosis of ARVC was 
based on a set of criteria recommend by the revised Task 
Force Criteria.[9] All included subjects had to meet two 
major, or one major plus two minor, or four minor diagnostic 
criteria to be diagnosed with ARVC. Data were collected by 
reviewing patients’ charts and investigations and variables of 
interest were recorded using a dedicated pro forma.
Follow-up
Follow-up was done at variable intervals after diagnosis of 
ARVC. Clinical information and variables of interest were 
documented on a dedicated pro forma by a physician during 
telephone contact or ambulatory visits.
CMR protocol
CMR was performed using a 1.5T Siemens Avanto scanner. 
A breath hold steady-state free-precession ECG-triggered 
sequence was used to evaluate global LV and RV function. 
In each patient, two long axis views (one vertical and one 
horizontal) and a set of contiguous short-axis views were 
acquired from the mitral plane to the apex with the following 
parameters: Slice thickness 7 mm, distance factor 25%, 
field of view 34 cm, matrix 192 × 192, flip angle 80, TR/TE 
58.74/1.12, and bandwidth 930 hz/px. In addition, two RV 
outflow tract (RVOT) views, one RV view showing inflow 
and outflow and axial stack for right ventricular slices were 
acquired.
Selected views of Turbo spin-echo T1-weighted images with 
and without FAT suppression were also acquired for each 
patient to look for fatty infiltration of the myocardium. Late 
gadolinium‐enhanced (LGE) images were obtained 8–10 min 
after bolus injection of gadolinium. Images were acquired in 
the same short-axis, long-axis, and RV views as used for cine 
CMR. e inversion time was optimized to null signal from 
the normal myocardium.
CMR analysis
All the images were analyzed by a reader who is qualified and 
experienced in cardiovascular imaging. e analysis of CMR 
images was done on third party software – Medis Q mass. 
e endocardial and epicardial borders of the LV and RV 
were drawn manually on the series of short-axis cine slices, at 
end-diastole, and end-systole to obtain end-diastolic volume 
(EDV), and end-systolic volume (ESV), respectively. e left 
and right ventricular ejection fraction (EF) was calculated 
from the EDV and ESV, and presented as percentages.
CMR challenges, findings in ARVC, and differential 
diagnosis
ECG irregularities and breath-holding issues are the main 
challenges during image acquisition in patients with 
suspected ARVC and may result in suboptimal image quality. 
Sometimes it is difficult to differentiate epicardial fat from 
fatty infiltration of the myocardium. Intramyocardial fat 
may also occur in older, obese patients and is not specific for 
ARVC in the absence of functional abnormalities.
CMR findings in ARVC include RV wall thinning, RVOT 
enlargement, prominent trabeculae, ventricular dilation, 
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Table 1: Revised 2010 task force criteria for ARVC.
1. Global or regional dysfunction and structural alterations
Major
2D Echo criteria
Regional RV akinesia, dyskinesia, or aneurysm AND 1 of the following measured at end diastole
PLAX RVOT≥32 mm (PLAX/BSA≥19 mm/m2), or 
PSAX RVOT≥36 mm (PSAX/BSA≥21 mm/m2), or
Fractional area change≤33%
CMR criteria
Regional RV akinesia or dyskinesia or dyssynchronous RV contraction AND 1 of the following
RV EDV/BSA≥110 mL/m2 (male) or≥100 mL/m2 (female
RV ejection fraction≤40%
RV Angiography Criteria
Regional RV akinesia, dyskinesia, or aneurysm
Minor
2D Echo Criteria
Regional RV akinesia or dyskinesia or dyssynchronous RV contraction AND 1 of the following measured at end diastole
PLAX RVOT ≥29–<32 mm (PLAX/BSA ≥16– <19 mm/m2), or
PSAX RVOT ≥32–<36 mm (PSAX/BSA ≥18– <21 mm/m2), or
Fractional area change>33%≤40%
CMR criteria
Regional RV akinesia or dyskinesia or dyssynchronous RV contraction AND 1 of the following:
RV EDV/BSA ≥100–110 mL/m2 (male) or ≥90–100 mL/m2 (female)
RV ejection fraction >40–≤45%
2. Tissue characterization of wall
Major
Residual myocytes<60% by morphometric analysis (or<50% if estimated), with fibrous replacement of the RV free wall myocardium in ≥1 
sample, with or without fatty replacement of tissue on endomyocardial biopsy
Minor
Residual myocytes 60–75% by morphometric analysis (or 50%–65% if estimated), with fibrous replacement of the RV free wall 
myocardium in ≥1 sample with or without fatty replacement of tissue on endomyocardial biopsy
3. Repolarization abnormalities
Major
Inverted T waves in right precordial leads (V1, V2, and V3) or beyond in individuals >14 years of age (in the absence of complete RBBB 
QRS≥120 ms)
Minor
Inverted T waves in V1 and V2 in individuals >14 years of age (in the absence of complete RBBB) or in V4, V5, and V6
Inverted T waves in leads V1, V2, V3, and V4 in individuals >14 years of age in the presence of a complete RBBB
4. Depolarization/conduction abnormalities
Major
Epsilon wave (reproducible low-amplitude signals between end of QRS complex to onset of T wave) in the right precordial leads (V1-V3)
Minor
Late potentials by SAECG in ≥1 of 3 parameters in the absence of a QRS of ≥110 ms on standard ECG:
Terminal activation duration ≥55 ms measured from the nadir of the S-wave until the end of all depolarization deflections (including R’) 
in V1, V2, or V3
5. Arrhythmias
Major
Non-sustained or sustained VT of LBBB morphology with superior axis
Minor
Non-sustained or sustained VT of RVOT configuration, LBBB morphology with inferior axis or of unknown axis
>500 PVCs per 24 h on Holter monitoring
(Contd...)
Journal of Clinical Imaging Science • 2020 • 10(48) | 4
Ahmed and Tipoo: Clinical presentation, cardiac magnetic resonance findings, and prognosis of patients with arrhythmogenic right 
ventricular cardiomyopathy - An experience from Pakistan
(n = 13, 76.5%) had dilated RV with reduced RV systolic 
function, three patients (17.6%) had dilated RV with normal 
systolic function, and one patient (5.9%) was found to have 
normal sized RV with reduced systolic function. LV was 
dilated in only two patients (11.8%) [Figure 1].
On CMR, all patients (n = 17, 100%) had LGE in the RV while fatty 
infiltrates were found in 14 (82.4%) patients [Figure 2]. Dilated 
RV with systolic dysfunction and regional dyskinesia was found 
in 14 (82.4%) patients, 2 (11.8%) patients had normal size RV with 
regional dyskinesia and systolic dysfunction, and 1 (5.9%) patient 
had regional right ventricular dyskinesia with normal size RV and 
Table 2: Baseline characteristics.
Demographics
Mean age ( years) 33.9±17.5
Males (%) 12 (70.6)
Symptoms (%)
Palpitations 6 (35.3)
Syncope 8 (47.1)
Dyspnea 2 (11.8)
Pedal edema 1 (5.9)
Family history (%)
SCD 3 (17.7)
ARVC 1 (5.9)
12 leads ECG findings (%)
Epsilon waves 3 (17.7)
RVH 1 (5.9)
RBBB 4 (23.5)
T wave inversion in precordial leads 6 (35.3)
Records not available 3 (17.7)
24 h ambulatory ECG (Holter) (%)
PVCs 5 (29.4)
Non-sustained VT 5 (29.4)
Sustained VT 1 (5.9)
Records not available 6 (35.3)
SCD: Sudden cardiac death, ARVC: Arrhythmogenic right ventricular 
cardiomyopathy, ECG: Electrocardiographic, RVH: Right ventricular 
hypertrophy, RBBB: Right bundle branch block, PVCs: Premature 
ventricular complexes, VT: Ventricular tachycardia
6. Family history
Major
ARVC in first degree relative who meets Task Force Criteria
ARVC confirmed pathologically at autopsy or surgery in first degree relative
Identification of pathogenic mutation categorized as associated or probably associated with ARVC in the patient under evaluation
Minor
History of ARVC in first degree relative in whom it is not possible to determine whether the family member meets Task Force Criteria
Premature sudden death (<35 years of age) due to suspected ARVC in a first degree relative
ARVC confirmed pathologically or by current Task Force Criteria in second-degree relative
ARVC: Arrhythmogenic right ventricular cardiomyopathy, RVOT: Right ventricular outflow tract, RV: Right Ventricle, EDV: End-diastolic volume, 
BSA: Body surface area, SAECG: Signal-averaged electrocardiogram
Table 1: (Continued).
global or regional systolic dysfunction, regional or focal 
areas of dyskinesia, and fibro-fatty replacement. ese 
abnormalities especially occur in predilection sites including 
the RV base and LV lateral wall. Common differentials 
of ARVC include conditions causing RV dilatation and 
dysfunction, Uhl’s anomaly, myocarditis, sarcoidosis, 
dysplastic tricuspid valve, and RV infarct.
Statistical analysis
We recorded the demographic details, presenting symptoms, 
family history, and results of investigations. After creating 
a database, we encoded our data. All statistical analyses 
were performed using the Statistical Package for the Social 
Sciences version 23. Continuous variables were expressed as 
mean value ± standard deviation and categorical variables 
were expressed as frequencies and percentage.
RESULTS
Table  2 shows the baseline characteristics, ECG and 
24 h ambulatory ECG findings in patients with ARVC. e 
majority (70.6%) of patients were male with a mean age of 
33.9 ± 17.5 years. ree (17.7%) of them had a family history 
of sudden cardiac death (SCD) and only one (5.9%) had 
family history of ARVC. e majority (47.1%) of patients 
presented with syncope, followed by palpitations (35.3%).
e most common ECG finding was T wave inversion in 
precordial leads in 6 (35.3%) patients, followed by right 
bundle branch block in 4 (23.5%) patients, epsilon wave was 
found in only 3 (17.7%) patients. On 24 hour ambulatory 
ECG monitoring, 5 (29.4%) patients had non-sustained 
ventricular tachycardia (VT), 5 (29.4%) patients were found 
to have premature ventricular complexes, and one (5.9%) 
patient showed sustained VT.
Table  3 shows the echocardiographic and CMR findings 
in patients with ARVC. On echocardiogram, mean left 
ventricular EF was 54.6 ± 4.1%. e majority of patients 
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Table 4: Follow-up.
Follow-up (n=14)
Mean duration of follow-up (months) 35.5±19.7
Hospital admissions during follow-up (mean) 2.3±1.0
Patients underwent ICD implantation (%) 4 (28.6)
Deaths (%) 3 (21.4)
Reason of hospitalization (%)
Arrhythmia 3 (21.4)
Heart failure 10 (71.4)
Others 1 (7.1)
Cause of death (%)
SCD 1 (7.1)
Decompensated heart failure 2 (14.3)
ICD: Implantable cardioverter defibrillator, SCD: Sudden cardiac death
Table 3: Echo and CMR findings.
Echocardiogram findings (%)
Mean EF 54.6±4.1
Patients with LV dilatation 2 (11.8)
Patients with only RA enlargement 13 (76.5)
Patients with Bi-atrial enlargement 4 (23.5)
Patients with RV dilatation without systolic 
dysfunction
3 (17.6)
Patients with RV dilatation with systolic 
dysfunction
13 (76.5)
RV systolic dysfunction without dilatation 1 (5.9)
CMR findings (%)
Patients with fatty infiltration 14 (82.4)
Late gadolinium enhancement 17 (100)
Normal sized RV with regional akinesia or 
Dyskinesia and preserved RV systolic function
1 (5.9)
Dilated RV with systolic dysfunction and regional 
akinesia/dyskinesia
14 (82.4)
Normal size RV with systolic dysfunction and 
regional dyskinesia/akinesia
2 (11.8)
LV envolvement 9 (52.9)
CMR: Cardiac magnetic resonance, EF: Ejection fraction, LV: Left 
ventricle, RA: Right atrial, RV: Right ventricle
normal systolic function [Figure 3]. Left ventricular involvement 
was found in more than half of the patients (n = 9, 52.9%).
Follow-up
Follow-up was available in 14 (82.4%) patients with a mean 
follow-up period of 35.5 ± 19.7 months [Table  4]. Half of 
the patients (n = 7, 50%) had at least one episode of VT on 
follow-up and only 4 (28.6%) patients underwent implantable 
cardioverter defibrillator (ICD) implantation for secondary 
prevention. All patients needed hospitalization during 
follow-up period and number of mean hospital admissions 
was 2.3 ± 1.0. Ten (71.4%) of the patients admitted for 
heart failure, 3 (21.4%) patients required admissions due to 
syncope/arrhythmia. ree (21.4%) of the 14 patients died 
during follow-up period, one (7.1%) had SCD and 2 (14.3%) 
died due to decompensated heart failure.
Figure  2: A 23-year-old woman with syncope. Cardiac magnetic 
resonance Turbo spin-echo T1-weighted image, showing fatty 
infiltration (arrow) of the myocardium.
Figure  1: A 27-year-old man with a history of syncope. Cardiac 
magnetic resonance delayed enhanced image with gadolinium, 
showing hyper enhancement (arrow) in the right and left ventricular 
walls.
Figure  3: (a and b) A 23-year-old woman with syncope. Cardiac 
magnetic resonance steady-state free precession still frames, 
showing focal aneurysmal areas (arrow) in the right ventricular free 
wall.
a b
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DISCUSION
is is the first study from this region, looking at the clinical 
presentation, CMR findings, and prognosis of patients 
with ARVC. e study results would help us understand 
the clinical presentation of ARVC and its prognosis in our 
population.
The prevalence of ARVC is one in 2000–5000 
individuals.[8] Classically, ARVC presents between the 
second and fourth decade of life. Syncope, palpitations, 
and SCD are the common presentations.[9] In our 
study, the mean age of patients was 33.9 years, and the 
main clinical presentation was syncope, followed by 
palpitations. In a study of 100 patients with ARVC, Dalal 
et al. reported an incidence of SCD of 23% in ARVC; 
other common presentations were palpitations (27%) and 
syncope (26%).[10]
e most common ECG finding of T wave inversion in 
precordial leads in our study is also in accordance with the 
literature which showed that T-wave inversion in the right 
precordial leads is present in up to 87% of adult patients with 
RV dominant ARVC and this is directly associated with RV 
dilatation and may extend to the left precordium with time.[11,12]
Echocardiography is usually the first-line imaging modality 
used for ARVC evaluation, as is the case in this study. 
However, echocardiography has its limitations in assessing 
the RV due to its complex geometry. On echocardiogram, 
right ventricular dilatation was the characteristic feature of 
ARVC in this study. In the literature, RV dilatation was found 
in more than 50% of patients, and it was directly associated 
with arrhythmic events.[13]
CMR has now emerged as the imaging modality of choice 
in ARVC. CMR allows not only the morphological and 
functional evaluation but also the tissue characterization 
of the myocardium. RV abnormalities in ARVC have been 
extensively described in the literature.[14]
One important finding of our study is the LV involvement in 
more than 52.9% of patients on CMR. LV involvement has 
been reported in ARVC subjects, with the majority having the 
advanced disease. Recent studies have shown that potential 
LV involvement may develop ahead of significant RV 
dysfunction in patients with ARVC, although RV dysfunction 
presents earlier because of its thin and distensible features, 
which allow it to be primarily affected.[15]
One reason for LV involvement in more than half of the 
patients could be the late presentation and delayed diagnosis 
due to less awareness and suboptimal medical facilities in 
this part of the world. is further signifies the importance 
of this study.
High mortality (21.4%) during follow-up in this study could 
be due to advanced disease at the time of presentation or due 
to less medical facilities available in the region. In a study 
from New Zealand, 30 patients with ARVC were followed for 
a mean follow-up of 7.4 years, and only two (6.6%) patients 
died during follow-up.[16]
Only four (28.6%) patients underwent ICD implantation 
for secondary prevention in our study while 26 patients 
underwent ICD implantation in the New Zealand study.[16] 
ICD implantation is an expensive but lifesaving treatment 
for secondary prevention and awareness about this 
treatment option needs to be increased among patients and 
cardiologists.
e findings of this study would have implications on clinical 
decision making and would help improve the outcomes of 
patients with ARVC in this region.
Limitations
is is a retrospective, single-center study conducted at a 
tertiary care hospital. e sample size is small, and follow-up 
is available in 14 out of 17 patients.
CONCLUSION
Arrhythmia related events are the main presenting symptoms 
of ARVC in this region. CMR is the best non-invasive 
imaging modality for ARVC, and left ventricular involvement 
in ARVC is not rare in this population. e mortality is 
relatively high probably due to advanced disease at the time 
of presentation and less medical facilities available in this 
region.
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